Many organizations are operating with constrained resources while trying to expand, launch new therapies, or scale manufacturing across regions. At the same time, regulatory expectations and ...
IEFA provides broad, low-cost exposure to developed markets outside the U.S. and Canada, with a 0.07% expense ratio. Read ...